Stanford Medicine Reveals: Tiny DNA Circles Defying Genetic Laws Drive Cancer Formation

This Pill Can Halve The Risk of Death After Lung Cancer, Scientists Say

Real-world data suggests stopping immunotherapy after two years is reasonable in patients with advanced lung cancer

New drug combination offers ovarian cancer breakthrough